Toni K Choueiri Selected Research

Toni K Choueiri Research Topics

Disease

349	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 12/2003
263	Neoplasms (Cancer) 04/2024 - 08/2004
71	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 03/2006
43	Carcinoma (Carcinomatosis) 12/2022 - 03/2006
42	Neoplasm Metastasis (Metastasis) 10/2023 - 03/2006
40	Kidney Neoplasms (Kidney Cancer) 01/2024 - 08/2007
25	Disease Progression 11/2023 - 12/2010
25	Fatigue 10/2021 - 06/2008
20	Hypertension (High Blood Pressure) 01/2023 - 06/2008
16	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 08/2008
13	Hypoxia (Hypoxemia) 10/2023 - 10/2006
11	Melanoma (Melanoma, Malignant) 01/2024 - 12/2014
10	COVID-19 08/2023 - 01/2020
8	Brain Neoplasms (Brain Tumor) 03/2024 - 09/2006
7	Adenocarcinoma 11/2022 - 06/2012
7	Breast Neoplasms (Breast Cancer) 05/2014 - 08/2004
6	Hematologic Neoplasms (Hematological Malignancy) 03/2023 - 12/2003
6	Exanthema (Rash) 01/2021 - 08/2004
6	Nausea 01/2021 - 05/2010
6	Diarrhea 01/2021 - 06/2008
6	Anemia 01/2018 - 11/2011
5	Hand-Foot Syndrome 01/2023 - 06/2008
5	Heart Failure 09/2015 - 02/2011
4	Carcinogenesis 11/2023 - 11/2012
4	Body Weight (Weight, Body) 05/2023 - 11/2015
4	Infections 03/2023 - 09/2005
4	Margins of Excision 10/2019 - 11/2011
4	Hypothyroidism 01/2018 - 01/2017
4	Pneumonia (Pneumonitis) 01/2017 - 07/2012
4	Transitional Cell Carcinoma 07/2012 - 04/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2021
3	Sarcoma (Soft Tissue Sarcoma) 02/2024 - 03/2011
3	Venous Thromboembolism 01/2023 - 12/2012

Drug/Important Bio-Agent (IBA)

78	Sunitinib (Sutent)FDA Link 04/2024 - 01/2008
66	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2015
62	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 10/2006
55	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2013
40	NivolumabIBA 01/2024 - 06/2015
37	cabozantinibIBA 08/2023 - 11/2015
32	AndrogensIBA 01/2022 - 03/2009
30	Everolimus FDA Link 01/2023 - 05/2011
28	pembrolizumabIBA 04/2024 - 01/2016
27	Tyrosine Kinase InhibitorsIBA 10/2023 - 01/2008
22	Axitinib (AG 013736)IBA 03/2024 - 06/2008
22	IpilimumabIBA 01/2024 - 01/2017
18	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 03/2009
17	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022 - 10/2009
16	PlatinumIBA 03/2022 - 04/2010
16	pazopanib FDA Link 01/2021 - 03/2011
15	Bevacizumab (Avastin)FDA Link 01/2023 - 05/2009
15	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2006
14	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2012
14	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 01/2008
12	atezolizumabIBA 01/2023 - 01/2018
12	RNA (Ribonucleic Acid)IBA 11/2022 - 07/2014
11	lenvatinibIBA 04/2024 - 03/2019
11	avelumabIBA 02/2024 - 01/2018
11	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2007
11	Hemoglobins (Hemoglobin)IBA 01/2018 - 03/2008
10	B7-H1 AntigenIBA 01/2022 - 07/2014
10	MTOR InhibitorsIBA 01/2022 - 08/2010
10	LigandsIBA 11/2020 - 01/2014
9	TOR Serine-Threonine KinasesIBA 08/2016 - 06/2009
8	Angiogenesis InhibitorsIBA 05/2014 - 10/2006
7	Messenger RNA (mRNA)IBA 10/2021 - 08/2014
7	Phosphotransferases (Kinase)IBA 10/2018 - 06/2008
6	Monoclonal AntibodiesIBA 01/2021 - 11/2015
6	ParaffinIBA 12/2018 - 11/2013
6	Formaldehyde (Formol)FDA Link 12/2018 - 07/2014
5	belzutifanIBA 11/2023 - 01/2021
5	Transcription Factors (Transcription Factor)IBA 11/2023 - 10/2009
5	Cell-Free Nucleic AcidsIBA 03/2022 - 01/2020
5	Alanine Transaminase (SGPT)IBA 01/2022 - 08/2013
5	Lipase (Acid Lipase)FDA Link 01/2021 - 08/2016
5	temsirolimus FDA Link 01/2020 - 05/2009
5	Docetaxel (Taxotere)FDA Link 01/2018 - 07/2011
5	Hormones (Hormone)IBA 01/2015 - 08/2004
4	Carbonic Anhydrase IXIBA 01/2024 - 05/2009
4	Circulating Tumor DNAIBA 11/2023 - 10/2017
4	Oxygen (Dioxygen)IBA 08/2023 - 10/2020
4	vinflunineIBA 01/2017 - 04/2010
3	Programmed Cell Death 1 ReceptorIBA 01/2024 - 02/2018
3	AntigensIBA 01/2024 - 01/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023 - 02/2012

Therapy/Procedure

291	Therapeutics 04/2024 - 08/2004
45	Immunotherapy 03/2024 - 11/2007
37	Drug Therapy (Chemotherapy) 03/2024 - 03/2006
34	Nephrectomy 10/2023 - 12/2008
20	Prostatectomy (Retropubic Prostatectomy) 10/2019 - 11/2008
17	Radiotherapy 07/2023 - 08/2008
10	Cystectomy 12/2021 - 08/2008
9	Brachytherapy 01/2019 - 10/2010
8	Castration 01/2023 - 10/2009
7	Neoadjuvant Therapy 12/2021 - 10/2012
6	Aftercare (After-Treatment) 08/2023 - 02/2011
6	Metastasectomy 01/2021 - 02/2011
4	Time-to-Treatment 01/2020 - 08/2010
4	Adjuvant Chemotherapy 02/2018 - 07/2014
4	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 05/2007
4	Salvage Therapy 01/2018 - 04/2010